ICD-10-CM Billable Code

F19.24

Other psychoactive substance dependence with psychoactive substance-induced mood disorder

Clinical Classification Guidelines

Inclusion Terms

  • Other (or unknown) substance use disorder, moderate, with other (or unknown) substance induced bipolar or related disorder
  • Other (or unknown) substance use disorder, moderate, with other (or unknown) substance induced depressive disorder
  • Other (or unknown) substance use disorder, severe, with other (or unknown) substance induced bipolar or related disorder
  • Other (or unknown) substance use disorder, severe, with other (or unknown) substance induced depressive disorder

Medical Intelligence & Overview

ICD-10 code F19.24 refers to a condition where an individual has a dependence on psychoactive substances, combined with mood disorders induced by those substances. This includes cases where moderate to severe substance dependence results in mood disturbances like depression or bipolar-like symptoms. These conditions highlight the complex relationship between substance use and mental health, emphasizing the importance of precise diagnosis and personalized treatment planning.

Causes & Symptoms

Clinical Causes: Chronic use of psychoactive substances such as alcohol, opioids, stimulants, sedatives, or hallucinogens. Repeated substance use leading to physical and psychological dependence. Genetic predisposition influencing both substance dependence and mood disorder susceptibility. Environmental factors such as stress, trauma, or social influences that contribute to both substance use and mood disturbances. Co-occurring mental health conditions, where underlying depression or bipolar symptoms may lead to substance use as a form of self-medication.

Key Symptoms: Altered mood states, including feelings of sadness, hopelessness, or irritability. Episodes of elevated mood, increased energy, or irritability suggestive of bipolar disorder. Cravings and compulsive substance use behaviors. Changes in sleep patterns, either insomnia or hypersomnia. Physical symptoms like fatigue, weight changes, or gastrointestinal issues. Impaired social or occupational functioning. Experiencing withdrawal symptoms when not using substances. Difficulty managing daily responsibilities due to mood swings or substance effects.

Diagnostic & Treatment

Diagnosis Path: Diagnosing this condition involves a comprehensive assessment including patient history, substance use patterns, and mental health evaluation. Healthcare providers may use structured interviews, questionnaires, and laboratory tests to confirm substance dependence and mood disorder symptoms. The assessment aims to determine the severity of dependence and the nature of the mood disorder, guiding effective treatment options.

Treatment Protocols: Treatment strategies typically include a combination of pharmacotherapy, psychotherapy, and support groups. Approaches may involve:

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is F19.24 a billable ICD-10 code?
Yes, F19.24 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report F19.24?
Clinical documentation must specify the nature of Other psychoactive substance dependence with psychoactive substance-induced mood disorder and any associated comorbidities for accurate reporting.

Cite this Clinical Reference